S A Bai

455 total citations
18 papers, 369 citations indexed

About

S A Bai is a scholar working on Pharmacology, Pharmacology and Analytical Chemistry. According to data from OpenAlex, S A Bai has authored 18 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 5 papers in Pharmacology and 5 papers in Analytical Chemistry. Recurrent topics in S A Bai's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Analytical Methods in Pharmaceuticals (5 papers). S A Bai is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Analytical Methods in Pharmaceuticals (5 papers). S A Bai collaborates with scholars based in United States, Russia and China. S A Bai's co-authors include U. Kristina Walle, Thomas Walle, Fred P. Abramson, Lawrence S. Olanoff, Joyce A. Goldstein, Joyce Blaisdell, Michael K. Stoskopf, Ron Paquette, Jörge E. Cortes and Charles L. Sawyers and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Pharmacology and Experimental Therapeutics and Anesthesiology.

In The Last Decade

S A Bai

17 papers receiving 356 citations

Peers

Countries citing papers authored by S A Bai

Since Specialization

Citations

This map shows the geographic impact of S A Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S A Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S A Bai more than expected).

Fields of papers citing papers by S A Bai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S A Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S A Bai. The network helps show where S A Bai may publish in the future.

Co-authorship network of co-authors of S A Bai

This figure shows the co-authorship network connecting the top 25 collaborators of S A Bai. A scholar is included among the top collaborators of S A Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S A Bai. S A Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Therapeutic effect of ginkgetin on smoke-induced airway inflammation by down-regulating the c/EBPβ signaling pathway and CCL2 expression 2024 ·Journal of Ethnopharmacology ·Tao Zhu, S A Bai, Guodong Wu, (unknown), Pei Zhang, Chunhua Fu, (unknown)	4
2	Octreotide pharmacokinetics and biochemical control of acromegaly using a subcutaneous octreotide hydrogel implant 2011 ·(unknown), (unknown), S A Bai, Xiaolei Hu, (unknown), (unknown), L. A. Frohman, Mônica R. Gadelha	0
3	Glucuronidation in the chimpanzee (*Pan troglodytes): Studies with acetaminophen, oestradiol and morphine 2006 ·Xenobiotica* ·Harvey Wong, (unknown), James E. Grace, Matthew Wright, (unknown), (unknown), (unknown), Scott Grossman, (unknown), (unknown), (unknown), S A Bai, David D. Christ, (unknown), (unknown), (unknown), (unknown)	5
4	A phase I study of BMS-354825 in patients with imatinib-resistant and intolerant chronic phase chronic myeloid leukemia (CML): Results from CA180002 2005 ·Journal of Clinical Oncology ·Moshe Talpaz, Hagop M. Kantarjian, Ron Paquette, Neil P. Shah, Jörge E. Cortes, John Nicoll, S A Bai, Fei Huang, Arthur P. DeCillis, Charles L. Sawyers	27
5	A phase I study of BMS-354825 in patients with imatinib-resistant and intolerant accelerated and blast phase chronic myeloid leukemia (CML): Results from CA180002 2005 ·Journal of Clinical Oncology ·Charles L. Sawyers, Neha Shah, Hagop M. Kantarjian, Jörge E. Cortes, Ron Paquette, John Nicoll, S A Bai, Edwin Clark, Arthur P. DeCillis, Moshe Talpaz	26
6	Pharmacokinetics of sulfadimethoxine and ormetoprim in a 5:1 ratio following intraperitoneal and oral administration, in the hybrid striped bass (Morone chrysops × Morone saxitalis) 2004 ·Journal of Veterinary Pharmacology and Therapeutics ·(unknown), S A Bai, Michael K. Stoskopf	20
7	Isolation of a new canine cytochrome P450 CDNA from the cytochrome P450 2C subfamily (CYP2C41) and evidence for polymorphic differences in its expression. 1998 ·PubMed ·Joyce Blaisdell, Joyce A. Goldstein, S A Bai	46
8	The influence of cimetidine on the pharmacokinetics of the enantiomers of verapamil in the dog during multiple oral dosing 1995 ·Journal of Veterinary Pharmacology and Therapeutics ·(unknown), (unknown), S A Bai	11
9	Effects of propranolol on the disposition and negative dromotropic activity of diltiazem in the dog during multiple dosing. 1993 ·Drug Metabolism and Disposition ·(unknown), (unknown), S A Bai	3
10	Pharmacokinetics and metabolism of a 4'-methylthio derivative of propranolol in the dog. 1989 ·Drug Metabolism and Disposition ·S A Bai, (unknown), (unknown), U. Kristina Walle, Carol A. Haney, (unknown), Jack K. Pruett, Thomas Walle	2
11	Sufentanil disposition during cardiopulmonary bypass 1987 ·Canadian Journal of Anesthesia/Journal canadien d anesthésie ·(unknown), (unknown), Joachim Jacobs, (unknown), S A Bai, J. G. Reves	21
12	ANESTHETIC AND OPERATIVE EFFECT ON PLASMA PROTEIN BINDING OF PROPRANOLOL AND VERAPAMIL DURING CARDIAC SURGERY 1985 ·Anesthesiology ·Robert A. Kates, S A Bai, J. G. Reves, (unknown)	1
13	Stereochemical composition of propranolol metabolites in the dog using stable isotope-labeled pseudoracemates. 1983 ·Drug Metabolism and Disposition ·Thomas Walle, (unknown), U. Kristina Walle, S A Bai	21
14	Stereoselective increase in propranolol bioavailability during chronic dosing in the dog. 1983 ·Journal of Pharmacology and Experimental Therapeutics ·S A Bai, (unknown), U. Kristina Walle, Thomas Walle	23
15	Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics. 1983 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), S A Bai, Fred P. Abramson	19
16	Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade. 1983 ·Journal of Pharmacology and Experimental Therapeutics ·S A Bai, Fred P. Abramson	12
17	Stereoselective binding of propranolol to human plasma, α1-acid glycoprotein, and albumin 1983 ·Clinical Pharmacology & Therapeutics ·U. Kristina Walle, Thomas Walle, S A Bai, Lawrence S. Olanoff	94
18	Interactions of phenobarbital with propranolol in the dog. 1. Plasma protein binding. 1982 ·Journal of Pharmacology and Experimental Therapeutics ·S A Bai, Fred P. Abramson	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact